Apolipoprotein E epsilon 4 affects new learning in cognitively normal individuals at risk for Alzheimer's disease. (Q52006074)

19 April 2018

title

Apolipoprotein E epsilon 4 affects new learning in cognitively normal individuals at risk for Alzheimer's disease. (English)

1 reference

19 April 2018

author

Sterling C. Johnson

3

1 reference

19 April 2018

Eric M. Reiman

4

object named as

Eric Reiman

1 reference

19 April 2018

Leslie C Baxter

1

1 reference

19 April 2018

Richard J Caselli

2

1 reference

19 April 2018

David Osborne

5

1 reference

19 April 2018

publication date

1 November 2003

1 reference

19 April 2018

published in

Neurobiology of Aging

1 reference

19 April 2018

volume

24

1 reference

19 April 2018

issue

7

1 reference

19 April 2018

page(s)

947-952

1 reference

19 April 2018

Preclinical prediction of AD using neuropsychological tests

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900006-X

7 January 2021

Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900006-X

7 January 2021

Preclinical memory decline in cognitively normal apolipoprotein E-epsilon4 homozygotes.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900006-X

7 January 2021

Preclinical cognitive decline in late middle-aged asymptomatic apolipoprotein E-e4/4 homozygotes: a replication study.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900006-X

7 January 2021

Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900006-X

7 January 2021

Population-based norms for the Mini-Mental State Examination by age and educational level

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900006-X

7 January 2021

APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900006-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900006-X

1 reference

7 January 2021

Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900006-X

7 January 2021

Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900006-X

7 January 2021

How does the apolipoprotein E genotype modulate the brain in aging and in Alzheimer's disease? A review of neuroimaging studies

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900006-X

7 January 2021

Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900006-X

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900006-X

7 January 2021

Life and death of neurons in the aging brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900006-X

7 January 2021

Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900006-X

7 January 2021

Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900006-X

7 January 2021

Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900006-X

7 January 2021

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900006-X

7 January 2021

Cognitive function and apolipoprotein E in very old adults: findings from the Nun Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900006-X

7 January 2021

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900006-X

7 January 2021

Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900006-X

7 January 2021

Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900006-X

7 January 2021

10.1016/S0197-4580(03)00006-X

Identifiers

DOI

1 reference

19 April 2018

PubMed ID

12928055

1 reference

19 April 2018